Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization

被引:51
|
作者
Itzhak, Y
Martin, JL
Black, MD
Ali, SF
机构
[1] Univ Miami, Sch Med, Dept Biochem & Mol Biol R62A, Miami, FL 33101 USA
[2] US FDA, Natl Ctr Toxicol Res, Div Neurotoxicol, Neurochem Lab, Jefferson, AR USA
关键词
methamphetamine; MPTP; melatonin; dopaminergic neurotoxicity; free radicals; locomotor activity; sensitization;
D O I
10.1016/S0028-3908(98)00067-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Methamphetamine (METH)- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity is thought to be associated with the formation of free radicals. Since evidence suggests that melatonin may act as a free radical scavenger and antioxidant, the present study was undertaken to investigate the effect of melatonin on METH- and MPTP-induced neurotoxicity. In addition, the effect of melatonin on METH-induced locomotor sensitization was investigated. The administration of METH (5 mg kg(-1) x 3) or MPTP (20 mg kg(-1) x 3) to Swiss Webster mice resulted in 45-57% depletion in the content of striatal dopamine and its metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, and 57-59% depletion in dopamine transporter binding sites. The administration of melatonin (10 mg kg(-1)) before each of the three injections of the neurotoxic agents (on day 1), and thereafter for two additional days, afforded a full protection against METH-ieduced depletion of dopamine and its metabolites and dopamine transporter binding sites. In addition, melatonin significantly diminished METH-induced hyperthermia. However, the treatment with melatonin had no significant effect on MPTP-induced depletion of the dopaminergic markers tested. In the set of behavioral experiments, we found that the administration of 1 mg kg(-1) METH to Swiss Webster mice for 5 days resulted in marked locomotor sensitization to a subsequent challenge injection of METH, as well as context-dependent sensitization (conditioning). The pretreatment with melatonin (10 mg kg(-1)) prevented neither the sensitized response to METH nor the development of conditioned locomotion. Results of the present study indicate that melatonin has a differential effect on the dopaminergic neurotoxicity produced by METH and MPTP. Since it is postulated that METH-induced hyperthermia is related to its neurotoxic effect, while regulation of body temperature is unrelated to MPTP-induced neurotoxicity or METH-induced locomotor sensitization, the protective effect of melatonin observed in the present study may be due primarily to diminishing METH-induced hyperthermia. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:781 / 791
页数:11
相关论文
共 50 条
  • [1] Methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice
    Itzhak, Y
    Martin, JL
    Ali, SF
    SYNAPSE, 1999, 34 (04) : 305 - 312
  • [2] 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine pretreatment attenuates methamphetamine-induced dopamine toxicity
    Kita, T
    Saraya, T
    Konishi, N
    Matsunari, Y
    Shimada, K
    Nakamura, M
    O'Hara, K
    Wagner, GC
    Nakashima, T
    PHARMACOLOGY & TOXICOLOGY, 2003, 92 (02): : 71 - 80
  • [3] Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
    Mohanakumar, KP
    Muralikrishnan, D
    Thomas, B
    BRAIN RESEARCH, 2000, 864 (02) : 281 - 290
  • [4] Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
    Dhanasekaran, Muralikrishnan
    Albano, Christian B.
    Pellet, Lori
    Karuppagounder, Senthilkumar S.
    Uthayathas, Subramaniam
    Suppiramaniam, Vishnu
    Brown-Borg, Holly
    Ebadi, Manuchair
    NEUROCHEMICAL RESEARCH, 2008, 33 (06) : 980 - 984
  • [5] Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice
    Muralikrishnan, D
    Mohanakumar, KP
    FASEB JOURNAL, 1998, 12 (10) : 905 - 912
  • [6] 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-INDUCED NEUROTOXICITY IN THE RAT - CHARACTERIZATION AND AGE-DEPENDENT EFFECTS
    JARVIS, MF
    WAGNER, GC
    SYNAPSE, 1990, 5 (02) : 104 - 112
  • [7] Acacetin Protects Dopaminergic Cells against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Neuroinflammation in Vitro and in Vivo
    Kim, Hyo Geun
    Ju, Mi Sun
    Ha, Sang Keun
    Lee, Hyangsook
    Lee, Hyejung
    Kim, Sun Yeou
    Oh, Myung Sook
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (08) : 1287 - 1294
  • [8] Unexpected Neuroprotective Effects of Loganin on 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Neurotoxicity and Cell Death in Zebrafish
    Yao, Li
    Peng, Shi-Xiao
    Xu, Yi-Da
    Lin, Stanley Li
    Li, Yu-Hong
    Liu, Chun-Jie
    Zhao, Hou-De
    Wang, Lin-Fang
    Shen, Yan-Qin
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (03) : 615 - 628
  • [9] 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic denervation potentiates gabaergic inhibition in the mouse neostriatum in vitro
    Schlosser, B
    Muller, A
    Sutor, B
    TenBruggencate, G
    NEUROSCIENCE, 1996, 71 (03) : 691 - 700
  • [10] Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
    Acuna-Castroviejo, Dario
    Tapias, Victor
    Lopez, Luis C.
    Doerrier, Carolina
    Camacho, Encarnacion
    Carrion, Maria D.
    Mora, Francisco
    Espinosa, Antonio
    Escames, Germaine
    BRAIN RESEARCH BULLETIN, 2011, 85 (3-4) : 133 - 140